Immune-targeting vaccine shows promise intercepting cancer in patients with Lynch Syndrome

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...
News-Medical.Net on MSN

Investigational cancer vaccine shows early promise for cancer prevention in Lynch syndrome

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...

Nouscom Highlights Potential of NOUS-209 to Intercept Cancer in Lynch Syndrome Carriers in Seminal Nature Medicine Publication

Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple cancersNOUS-209 is an ...